BR112015010877A2 - artigos antimicrobianos produzidos por fabricação de aditivos - Google Patents

artigos antimicrobianos produzidos por fabricação de aditivos

Info

Publication number
BR112015010877A2
BR112015010877A2 BR112015010877A BR112015010877A BR112015010877A2 BR 112015010877 A2 BR112015010877 A2 BR 112015010877A2 BR 112015010877 A BR112015010877 A BR 112015010877A BR 112015010877 A BR112015010877 A BR 112015010877A BR 112015010877 A2 BR112015010877 A2 BR 112015010877A2
Authority
BR
Brazil
Prior art keywords
pump
antibiotic
implantable device
articles produced
additive manufacturing
Prior art date
Application number
BR112015010877A
Other languages
English (en)
Portuguese (pt)
Inventor
Rodgers Luke
Petrak Martin
Original Assignee
Orthopaedic Innovation Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50730434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112015010877(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orthopaedic Innovation Center Inc filed Critical Orthopaedic Innovation Center Inc
Publication of BR112015010877A2 publication Critical patent/BR112015010877A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14276—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/375—Constructional arrangements, e.g. casings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/375—Constructional arrangements, e.g. casings
    • A61N1/37512—Pacemakers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/022—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the choice of material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y70/00—Materials specially adapted for additive manufacturing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y80/00—Products made by additive manufacturing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C19/00—Dental auxiliary appliances
    • A61C19/06—Implements for therapeutic treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0205—Materials having antiseptic or antimicrobial properties, e.g. silver compounds, rubber with sterilising agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/04—General characteristics of the apparatus implanted
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/753—Medical equipment; Accessories therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/753—Medical equipment; Accessories therefor
    • B29L2031/7532—Artificial members, protheses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y10/00—Processes of additive manufacturing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Manufacturing & Machinery (AREA)
  • Anesthesiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mechanical Engineering (AREA)
  • Neurosurgery (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Dentistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Prostheses (AREA)
BR112015010877A 2012-11-14 2013-11-14 artigos antimicrobianos produzidos por fabricação de aditivos BR112015010877A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261726433P 2012-11-14 2012-11-14
US201361895130P 2013-10-24 2013-10-24
PCT/CA2013/050871 WO2014075185A1 (en) 2012-11-14 2013-11-14 Antimicrobial articles produced by additive manufacturing

Publications (1)

Publication Number Publication Date
BR112015010877A2 true BR112015010877A2 (pt) 2017-07-11

Family

ID=50730434

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015010877A BR112015010877A2 (pt) 2012-11-14 2013-11-14 artigos antimicrobianos produzidos por fabricação de aditivos

Country Status (12)

Country Link
US (2) US10905740B2 (enExample)
EP (1) EP2919823B1 (enExample)
JP (1) JP2015536726A (enExample)
KR (1) KR20150090110A (enExample)
CN (2) CN109453433A (enExample)
AU (1) AU2013344733B2 (enExample)
BR (1) BR112015010877A2 (enExample)
CA (1) CA2885334C (enExample)
IL (1) IL238848B (enExample)
IN (1) IN2015DN04046A (enExample)
MX (1) MX2015006002A (enExample)
WO (1) WO2014075185A1 (enExample)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010096771A2 (en) 2009-02-20 2010-08-26 The General Hospital Corporation Dba High temperature melting
CN109453433A (zh) 2012-11-14 2019-03-12 整形外科创新中心公司 通过添加制造生产的抗微生物物品
TWI522430B (zh) * 2014-02-20 2016-02-21 研能科技股份有限公司 立體成型組合物
AU2015234581B2 (en) * 2014-03-25 2018-06-21 Orthopaedic Innovation Centre Inc. Antimicrobial articles produced by additive manufacturing
MX2016015171A (es) * 2014-05-18 2017-07-14 M Lacerda Carlos Composicion antibacteriana, estuches antibacterianos y accesorios para electronicos portátiles, y metodo de hacer estuches antibacterianos para electronicos portatiles.
WO2016022661A1 (en) * 2014-08-05 2016-02-11 University Of Washington Three-dimensional printed mechanoresponsive materials and related methods
WO2016025388A1 (en) * 2014-08-10 2016-02-18 Louisiana Tech University Foundation; A Division Of Louisiana Tech University Foundation , Inc. Methods and devices for three-dimensional printing or additive manufacturing of bioactive medical devices
KR101701498B1 (ko) * 2014-09-05 2017-02-03 (주)비앤케이 항균성을 가지는 3d 프린터용 필라멘트 제조 방법 및 이에 의해 제조된 항균성을 가지는 3d 프린터용 필라멘트
CN114670437B (zh) * 2014-09-08 2025-10-31 兰开夏大学 固体剂型生产
CN104260359B (zh) * 2014-09-16 2016-09-07 苏州佳世达光电有限公司 3d打印机及其光源选取方法
JP6537250B2 (ja) * 2014-11-13 2019-07-03 ユニチカ株式会社 ポリ乳酸系モノフィラメント
US9757573B2 (en) * 2014-12-02 2017-09-12 Heraeus Deutschland GmbH & Co. KG Implantable medical device housing having integrated features
CH710441A2 (de) 2014-12-02 2016-06-15 Rowak Ag Pulverförmige Zusammensetzungen aus thermoplastischen Kunststoffen und Verwendung der Zusammensetzungen.
US10524915B2 (en) * 2014-12-09 2020-01-07 Rutgers, The State University Of New Jersey Three-dimensional pre-vascularized scaffold for bone regeneration
KR102573610B1 (ko) * 2015-02-16 2023-08-31 테크레스 에스.피.에이. 인체 내에 이식되는 장치 또는 관절 스페이서의 성형을 위한 재료
US12291823B2 (en) * 2015-04-15 2025-05-06 Robert A. Flitsch Methods, materials and apparatus for mobile additive manufacturing of advanced structures and roadways
US20180168811A1 (en) * 2015-06-15 2018-06-21 Rowan University Novel biodegradable and non-biodegradable 3d printed implants as a drug delivery system
KR20180029246A (ko) * 2015-07-17 2018-03-20 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 고체 임의 형상 제작을 위한 열가소성 폴리우레탄 조성물
AU2016297508A1 (en) * 2015-07-17 2018-01-25 Lubrizol Advanced Materials, Inc. Thermoplastic polyurethane compositions for solid freeform fabrication
GB201516943D0 (en) * 2015-09-24 2015-11-11 Victrex Mfg Ltd Polymeric materials
AU2016352992A1 (en) * 2015-11-12 2018-05-24 The General Hospital Corporation Methods of making therapeutic polymeric material
EP3389570B1 (en) 2015-12-16 2024-04-17 Nuvasive, Inc. Porous spinal fusion implant
CN105457103B (zh) * 2015-12-31 2019-04-02 复旦大学附属华山医院 一种3d打印周围神经导管及其制备方法
GB201601865D0 (en) * 2016-02-02 2016-03-16 Ucl Business Plc Oral dosage products and processes
EP3411422A1 (en) 2016-02-05 2018-12-12 The General Hospital Corporation Drug eluting polymer composed of biodegradable polymers applied to surface of medical device
AU2017235599A1 (en) * 2016-03-18 2018-07-26 Grünenthal GmbH Combination of drugs having different potency
US9863065B2 (en) 2016-04-13 2018-01-09 Xerox Corporation Polymer coated sulfonated polyester—silver nanoparticle composite filaments and methods of making the same
US9908977B2 (en) 2016-04-13 2018-03-06 Xerox Corporation Styrenic-based polymer coated silver nanoparticle-sulfonated polyester composite powders and methods of making the same
US9877485B2 (en) 2016-04-13 2018-01-30 Xerox Corporation Silver polyester-sulfonated nanoparticle composite filaments and methods of making the same
US9909013B2 (en) 2016-04-13 2018-03-06 Xerox Corporation Silver nanoparticle-sulfonated polyester composite powders and methods of making the same
ES2857858T3 (es) * 2016-04-28 2021-09-29 Straumann Holding Ag Sistema y procedimiento de fabricación de un dispositivo dental
DE102016110500B4 (de) * 2016-06-07 2019-03-14 Karl Leibinger Medizintechnik Gmbh & Co. Kg Implantatherstellverfahren mittels additivem selektivem Lasersintern und Implantat
US10405540B2 (en) 2016-07-06 2019-09-10 Xerox Corporation Anti-bacterial metallo ionomer polymer nanocomposite filaments and methods of making the same
US10113059B2 (en) 2016-07-06 2018-10-30 Xerox Corporation Anti-bacterial metallo ionomer polymer nanocomposite powders and methods of making the same
EP3509654B1 (de) * 2016-09-08 2023-07-12 Karl Leibinger Medizintechnik GmbH & Co. KG Verfahren zum herstellen eines implantats mittels calciumsalz-enthaltendem verbundpulver mit mikrostrukturierten teilchen
BR112019004490B1 (pt) * 2016-09-08 2022-05-24 Karl Leibinger Medizintechnik Gmbh & Co. Kg Processo para a produção de um implante com pó compósito contendo carbonato de cálcio com partículas microestruturadas
US9875958B1 (en) * 2016-11-09 2018-01-23 International Business Machines Corporation Trace/via hybrid structure and method of manufacture
EP3320898A1 (en) * 2016-11-11 2018-05-16 ratiopharm GmbH Dosage form comprising a carrier structure and method for manufacturing the dosage form
CN106727692A (zh) * 2016-11-24 2017-05-31 浙江三禾纳米科技有限公司 一种皮肤抗菌喷剂及其制备方法
WO2018112058A1 (en) * 2016-12-18 2018-06-21 Cardiac Pacemakers, Inc. Infection fighting drug eluting lead boot
WO2018151725A1 (en) * 2017-02-15 2018-08-23 Hewlett-Packard Development Company, L.P. Printed support structure
KR102626745B1 (ko) 2017-05-26 2024-01-17 인피니트 머티리얼 솔루션즈, 엘엘씨 수용성 중합체 조성물
RU2020107391A (ru) * 2017-07-25 2021-08-25 Пк Мед Сас Способ получения композиции для доставки лекарственного средства
EP3755785A1 (en) 2018-02-22 2020-12-30 The Procter & Gamble Company Methods for making unit dose articles
US11453197B2 (en) * 2018-07-03 2022-09-27 Hamilton Sundstrand Corporation Antimicrobial surfaces for flow path components
EP3934430A4 (en) * 2019-03-07 2022-11-16 Board of Regents of the University of Nebraska Antimicrobial scaffolds
CN110180033A (zh) * 2019-05-16 2019-08-30 深圳市第二人民医院 载甲基莲心碱的三维多孔支架及其制备方法
RU196412U1 (ru) * 2019-10-02 2020-02-28 Владимир Юрьевич Гречухин Устройство синхронизации работы деструктора и насоса для подачи охлаждающей жидкости
WO2021156894A1 (en) * 2020-02-05 2021-08-12 3D Implants Fabrication of 3d-printed fracture-specific orthopaedic cast
WO2021178677A1 (en) 2020-03-04 2021-09-10 Ascend Performance Materials Operations Llc Antimicrobial/antiviral plastics and molded products
US12371581B2 (en) 2020-03-25 2025-07-29 Infinite Material Solutions, Llc High performance water soluble polymer compositions
CN111995847A (zh) * 2020-07-31 2020-11-27 陕西科技大学 一种可抗菌的3d打印线材的制备方法
US12397499B2 (en) * 2020-08-13 2025-08-26 The Hong Kong Polytechnic University Three-dimensional printing antimicrobial products
CN112743835B (zh) * 2020-12-25 2022-07-01 聊城市东昌府区妇幼保健院 一种医用护具及其制造方法
US11970600B2 (en) 2021-03-31 2024-04-30 The General Hospital Corporation Di-cumyl peroxide crosslinking of UHMWPE
DE102021214529A1 (de) 2021-12-16 2023-06-22 Volkswagen Aktiengesellschaft Filament-Element für additive Fertigungsverfahren, Extrudiervorrichtung zur Herstellung eines Filament-Elements, Produktionsvorrichtung zur additiven Herstellung von 3D-Bauteilen

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642003A (en) 1969-08-26 1972-02-15 Sutures Inc Sutures having long-lasting germicidal properties
US3862304A (en) 1971-06-03 1975-01-21 Sutures Inc Sutures having long-lasting germicidal properties
JP3119509B2 (ja) * 1991-09-20 2000-12-25 ユニチカ株式会社 水中資材用繊維
US5217493A (en) 1992-03-11 1993-06-08 Board Of Regents, The University Of Texas System Antibacterial coated medical implants
US5490962A (en) 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
US6176874B1 (en) * 1993-10-18 2001-01-23 Masschusetts Institute Of Technology Vascularized tissue regeneration matrices formed by solid free form fabrication techniques
US5626611A (en) * 1994-02-10 1997-05-06 United States Surgical Corporation Composite bioabsorbable materials and surgical articles made therefrom
DE19527630A1 (de) 1995-07-28 1997-01-30 Hoechst Ag Polyhydroxyalkylamidobetaine
US6341952B2 (en) * 1997-03-20 2002-01-29 Therics, Inc. Fabrication of tissue products with additives by casting or molding using a mold formed by solid free-form methods
US20050023710A1 (en) * 1998-07-10 2005-02-03 Dmitri Brodkin Solid free-form fabrication methods for the production of dental restorations
US6454811B1 (en) * 1998-10-12 2002-09-24 Massachusetts Institute Of Technology Composites for tissue regeneration and methods of manufacture thereof
AU6526100A (en) * 1999-08-06 2001-03-05 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
WO2002085246A2 (en) * 2001-04-19 2002-10-31 Case Western Reserve University Fabrication of a polymeric prosthetic implant
WO2003034314A1 (en) 2001-10-15 2003-04-24 The Regents Of The University Of Michigan Solid freeform fabrication of structurally engineered multifunctional devices
US7509240B2 (en) 2001-10-15 2009-03-24 The Regents Of The University Of Michigan Solid freeform fabrication of structurally engineered multifunctional devices
EP1608292A4 (en) 2003-03-13 2007-10-31 Univ Rice William M INJECTABLE AND PRE-PRODUCED COMPOSITE MATERIAL AS A BONE REPLACEMENT AND METHOD FOR PRODUCING SUCH A BONE REPLACEMENT MATERIAL
EP1646410B1 (en) * 2003-07-17 2009-11-11 Bioretec Oy Synthetic, bioabsorbable polymer materials and implants
AU2004291022C1 (en) * 2003-11-21 2009-11-12 Osteopore International Pte Ltd Bioabsorbable plug implants and method for bone tissue regeneration
US7357810B2 (en) * 2003-12-18 2008-04-15 Ethicon, Inc. High strength suture with absorbable core and suture anchor combination
TW200604249A (en) * 2004-03-24 2006-02-01 Commw Scient Ind Res Org Biodegradable polyurethane and polyurethane ureas
JP5756588B2 (ja) * 2005-07-15 2015-07-29 ミセル テクノロジーズ、インコーポレイテッド 制御されたモルホロジーの薬剤粉末を含むポリマーコーティング
AU2006308534B2 (en) * 2005-11-01 2013-02-07 Warsaw Orthopedic, Inc. Bone matrix compositions and methods
FR2898039B1 (fr) 2006-03-03 2008-06-27 Ceravic Sas Soc Par Actions Si Implant provisoire comprenant deux actifs.
US8178012B1 (en) * 2006-04-06 2012-05-15 Ivoclar Vivadent Ag Shaded zirconium oxide articles and methods
DE102006017595A1 (de) 2006-04-13 2007-10-18 Friedrich-Baur Gmbh Verfahren zum Herstellen eines biokompatiblen Gerüstes, insbesondere zur Herstellung eines Implantates
US8974814B2 (en) * 2007-11-12 2015-03-10 California Institute Of Technology Layered drug delivery polymer monofilament fibers
US20110144752A1 (en) * 2008-08-14 2011-06-16 Defelice Scott F Customized implants for bone replacement
CN105126179B (zh) * 2009-07-14 2018-09-25 波利皮得有限公司 持续释放药物载体组合物
IL203403A (en) * 2010-01-19 2016-08-31 Cupron Inc Biofilm resistant materials
JP6027533B2 (ja) * 2010-08-20 2016-11-16 ケース ウェスタン リザーブ ユニバーシティＣａｓｅ Ｗｅｓｔｅｒｎ Ｒｅｓｅｒｖｅ Ｕｎｉｖｅｒｓｉｔｙ インプラントの連続デジタル光処理による付加的製造
US8920697B2 (en) 2010-09-17 2014-12-30 Stratasys, Inc. Method for building three-dimensional objects in extrusion-based additive manufacturing systems using core-shell consumable filaments
EP2629812A1 (en) 2010-10-19 2013-08-28 Aarhus Universitet Tissue scaffold with controlled drug release
CN102302386B (zh) 2011-06-24 2013-10-16 上海大学 药物缓释型仿生骨支架的制备方法
CN109453433A (zh) 2012-11-14 2019-03-12 整形外科创新中心公司 通过添加制造生产的抗微生物物品

Also Published As

Publication number Publication date
CA2885334C (en) 2016-03-08
WO2014075185A1 (en) 2014-05-22
AU2013344733B2 (en) 2017-02-23
KR20150090110A (ko) 2015-08-05
CN109453433A (zh) 2019-03-12
MX2015006002A (es) 2016-02-05
JP2015536726A (ja) 2015-12-24
AU2013344733A1 (en) 2015-05-28
CN105050632A (zh) 2015-11-11
IL238848B (en) 2019-10-31
EP2919823B1 (en) 2019-07-03
EP2919823A4 (en) 2016-07-13
IN2015DN04046A (enExample) 2015-10-02
US11666626B2 (en) 2023-06-06
EP2919823A1 (en) 2015-09-23
IL238848A0 (en) 2015-06-30
CA2885334A1 (en) 2014-05-22
US20150290280A1 (en) 2015-10-15
US20210113651A1 (en) 2021-04-22
US10905740B2 (en) 2021-02-02

Similar Documents

Publication Publication Date Title
BR112015010877A2 (pt) artigos antimicrobianos produzidos por fabricação de aditivos
MX386251B (es) Novedosos fármacos de alta penetración y sus composiciones para el tratamiento de enfermedades de parkinson.
BR112019023985A2 (pt) sistema de autocorreção e componentes e métodos relacionados
UA108885C2 (uk) Композиція рисперидону для ін'єкційної депо-форми
WO2021050953A8 (en) Compositions and methods for the delivery of therapeutic biologics for treatment of disease
IN2013DN02524A (enExample)
MX2021012050A (es) Formulaciones de proteinas liquidas que contienen agentes reductores de viscosidad.
BR112016021130A2 (pt) Nanopartículas terapêuticas, composição farmacêutica compreendendo as referidas nanopartículas, processo para a preparação e uso das mesmas
MX378183B (es) Composiciones de profarmacos de alta penetracion y composiciones farmaceuticas de los mismos para el tratamiento de afecciones pulmonares.
WO2015017609A8 (en) Systems and methods for drug delivery, treatment, and monitoring
BR112015025072A2 (pt) novo derivado de ácido 3-(4-(benziloxi)fenil)hex-4-inóico, método de preparação do mesmo e composição farmacêutica para prevenção e tratamento de doenças metabólicas incluindo o mesmo como ingrediente eficaz
IN2014DN08870A (enExample)
WO2016100949A3 (en) Method and compositions for dissolving or solubilizing therapeutic agents
MX383077B (es) Composiciones farmaceuticas para la administracion intraocular que comprenden un agente antibacteriano y un agente antiinflamatorio.
EA201691008A1 (ru) 7-бензил-4-(2-метилбензил)-2,4,6,7,8,9-гексагидроимидазо[1,2-a]пиридо[3,4-e]пиримидин-5(1h)-он, его соли и способы применения
AR099558A1 (es) Régimen de dosaje del compuesto fgf-18
CY1124527T1 (el) Σκευασματα αναστολεα pi3k/mtor για ενδοφλεβια χορηγηση
BR112018008769A2 (pt) formulações farmacêuticas, formulações líquidas aquosa reconstituída e liofilizada, seringa, método de fabricação de uma formulação farmacêutica, método para tratamento de uma doença e uso de uma formulação reconstruída
CL2008001332A1 (es) Uso de temozolomida para preparar un medicamento util para el tratamiento de un desorden proliferativo.
EA201391063A1 (ru) Аполипопротеин a-iv в качестве антидиабетического пептида
EP4249069A3 (en) Aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea
WO2014184248A3 (en) Trpa1 antagonist compounds
PH12017501005A1 (en) Injectable formulations of paracetamol
BR112018009994A8 (pt) composição com propriedades resistentes a pragras
RU2012131719A (ru) Способ лечения экспериментального панкреонекроза

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]